Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade.
Schiffrin
Ernesto L
EL
Touyz
Rhian M
RM
D000804:Angiotensin II / Q000502:physiology*; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D001713:Biphenyl Compounds; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D007249:Inflammation; D018836:Inflammation Mediators / Q000009:adverse effects / Q000276:immunology; D018384:Oxidative Stress / Q000276:immunology; D017382:Reactive Oxygen Species / Q000276:immunology; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D018836:Inflammation Mediators; D017382:Reactive Oxygen Species; D013777:Tetrazoles; D000804:Angiotensin II; C081643:candesartan